DexCom (DXCM) Reiterated at Buy by Benchmark After Investor Event

May 15, 2026 7:54 AM

Benchmark analyst Bruce Jackson reiterated a Buy rating and $77.00 price target on DexCom (NASDAQ: DXCM).The analyst commented, "Dexcom hosted ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found